Quid Pro Quo (QPQ) Tracker
← Back to Influence Map
Entity DossierOrganization

INSULET CORPORATION

MA · US

fara

Tracked direct giving

$0

LDA reported lobbying spend

$1,000,000

Connections

5

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$1.7M
MMMMedicare/Medicaid
$190K

Lobbying Firms Retained

In-house lobbyists (filed as its own registrant)$1.4M
TODD STRATEGY GROUP$260K
PRIME POLICY GROUP$100K

Bills Referenced in Lobbying Filings

PBMinsulin

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Lobbied onPharmacy Benefit Manager Reform ActLDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $40,000Source
RetainedPrime PolicyHired PRIME POLICY GROUP to lobby on Insulin Price CapsSource
Lobbied onInsulin Price Caps - State-Level LegislationLDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $30,000Source
RetainedPRIME POLICY GROUPHired PRIME POLICY GROUP to lobby on Insulin Price CapsSource
RetainedTODD STRATEGY GROUPHired TODD STRATEGY GROUP to lobby (2nd Quarter (Apr 1 - June 30) 2025)Source